Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Depreciation & Amortization (CF): 2019-2025

Historic Depreciation & Amortization (CF) for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to $66,000.

  • Benitec Biopharma's Depreciation & Amortization (CF) fell 46.15% to $14,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $66,000, marking a year-over-year decrease of 24.14%. This contributed to the annual value of $66,000 for FY2025, which is 24.14% down from last year.
  • Latest data reveals that Benitec Biopharma reported Depreciation & Amortization (CF) of $66,000 as of FY2025, which was down 24.14% from $87,000 recorded in FY2024.
  • In the past 5 years, Benitec Biopharma's Depreciation & Amortization (CF) registered a high of $231,000 during FY2021, and its lowest value of $66,000 during FY2025.
  • In the last 3 years, Benitec Biopharma's Depreciation & Amortization (CF) had a median value of $87,000 in 2024 and averaged $96,333.
  • In the last 5 years, Benitec Biopharma's Depreciation & Amortization (CF) grew by 21.58% in 2021 and then slumped by 36.03% in 2024.
  • Over the past 5 years, Benitec Biopharma's Depreciation & Amortization (CF) (Yearly) stood at $231,000 in 2021, then dropped by 27.71% to $167,000 in 2022, then fell by 18.56% to $136,000 in 2023, then tumbled by 36.03% to $87,000 in 2024, then decreased by 24.14% to $66,000 in 2025.